OUR FOCUS
Harnessing Transformative Trends
From advanced imaging systems to wearable devices and telemedicine platforms, Medical Technology’s boundaries are blurring with other subsectors to play a central role in improving patient outcomes and healthcare delivery.
Our Medical Technology team supports both emerging and established companies, serving as a valued partner through M&A, capital raising, and strategic transactions.
Recent transactions
$50 Million
Sole Agent
At-the-Market Facility
March 2025
$350 Million
Joint Bookrunner
Rule 144A Convertible Senior Notes Offering
March 2025
$75 Million
Joint Bookrunner
Follow-On
February 2025
$235 Million
Joint Lead Bookrunner
Initial Public Offering
January 2025
Featured Insights
Articles
August 2026
The Opportunity for Innovation in Primary Progressive Multiple Sclerosis
Podcasts
August 2026
Can Health Economics Lead to Better Biotech? A Conversation with Rob Abbott
Featured Research
July 2026
